kitio.aiArteraAI vs SOPHiA GENETICS
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. ArteraAI starts at See pricing page and SOPHiA GENETICS starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
- Genomic data analysis
- Oncology applications
- Rare disease analysis
- Liquid biopsy support
- Biopharma analytics
| Feature | ArteraAI | SOPHiA GENETICS |
|---|---|---|
| Best for | AI pathology tests that predict cancer outcomes and therapy benefit | AI genomics and radiomics platform for cancer and rare disease labs |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Artera | SOPHiA GENETICS |
| Based in | United States | Switzerland |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
ArteraAI starts at See pricing page and SOPHiA GENETICS starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Nov 5, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
ArteraAI
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
SOPHiA GENETICS
- Covers many cancer and rare disease tests
- Cloud-based, so labs avoid local pipelines
- Used by hospitals and biopharma
- Only for clinical labs and researchers
- No public pricing
- Requires sequencing setup
Which one should you choose?
Choose ArteraAI if you want:
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Watch out: ordered by clinicians only.
Choose SOPHiA GENETICS if you want:
- Covers many cancer and rare disease tests
- Cloud-based, so labs avoid local pipelines
- Used by hospitals and biopharma
Watch out: only for clinical labs and researchers.
ArteraAI vs SOPHiA GENETICS FAQ
What is the difference between ArteraAI and SOPHiA GENETICS?
ArteraAI: AI pathology tests that predict cancer outcomes and therapy benefit. SOPHiA GENETICS: AI genomics and radiomics platform for cancer and rare disease labs. Both are legal, finance & hr tools.
Is ArteraAI or SOPHiA GENETICS cheaper?
ArteraAI starts at See pricing page and SOPHiA GENETICS starts at See pricing page. Check both pricing pages for current plans.
Do ArteraAI and SOPHiA GENETICS have free plans?
ArteraAI: No. SOPHiA GENETICS: No.
Who makes ArteraAI?
ArteraAI is made by Artera, based in United States.
Who makes SOPHiA GENETICS?
SOPHiA GENETICS is made by SOPHiA GENETICS, based in Switzerland.
Which should I choose, ArteraAI or SOPHiA GENETICS?
Choose ArteraAI if you value fda de novo authorization and listed in nccn prostate guidelines. Choose SOPHiA GENETICS if you value covers many cancer and rare disease tests and cloud-based, so labs avoid local pipelines.